Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HKMPFOTCMKTS:HTCMYOTCMKTS:LEGIFOTCMKTS:OUTKY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHKMPFHikma Pharmaceuticals$27.73$26.54$22.56▼$28.92$6.15B0.571,600 shsN/AHTCMYHitachi Construction Machinery$59.31$56.71$40.85▼$60.02$6.31B0.491,027 shs95 shsLEGIFLEG Immobilien$83.09$78.54$70.74▼$104.10$6.16B0.85330 shs3 shsOUTKYOutokumpu Oyj$1.73$1.82$1.37▼$2.04$1.58B0.61,913 shsN/AMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHKMPFHikma Pharmaceuticals0.00%0.00%+5.86%+2.05%+13.18%HTCMYHitachi Construction Machinery0.00%0.00%-1.19%+15.38%+5.81%LEGIFLEG Immobilien0.00%0.00%0.00%+3.86%-6.77%OUTKYOutokumpu Oyj0.00%0.00%+1.76%-2.81%-14.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHKMPFHikma PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AHTCMYHitachi Construction MachineryN/AN/AN/AN/AN/AN/AN/AN/ALEGIFLEG ImmobilienN/AN/AN/AN/AN/AN/AN/AN/AOUTKYOutokumpu OyjN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHKMPFHikma Pharmaceuticals 3.50Strong BuyN/AN/AHTCMYHitachi Construction Machinery 0.00N/AN/AN/ALEGIFLEG Immobilien 2.00HoldN/AN/AOUTKYOutokumpu Oyj 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest OUTKY, HTCMY, LEGIF, and HKMPF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025HKMPFHikma PharmaceuticalsBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform4/3/2025LEGIFLEG ImmobilienBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHKMPFHikma Pharmaceuticals$2.88B2.14$3.28 per share8.46$10.03 per share2.76HTCMYHitachi Construction Machinery$9.74B0.65$12.81 per share4.63N/A∞LEGIFLEG Immobilien$1.34B4.59$6.59 per share12.61$109.36 per share0.76OUTKYOutokumpu Oyj$6.43B0.25$1.54 per share1.12N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHKMPFHikma Pharmaceuticals$190MN/A0.00∞N/AN/AN/AN/A8/7/2025 (Estimated)HTCMYHitachi Construction Machinery$643.73M$5.4510.8811.04N/A6.10%10.67%4.73%7/25/2025 (Estimated)LEGIFLEG Immobilien-$1.70B$2.45N/A∞N/A-52.85%5.27%2.02%8/7/2025 (Estimated)OUTKYOutokumpu Oyj-$43.29M-$0.04N/A8.24N/A-0.66%-1.06%-0.65%8/14/2025 (Estimated)Latest OUTKY, HTCMY, LEGIF, and HKMPF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025OUTKYOutokumpu Oyj-$0.01-$0.02-$0.01-$0.02$1.53 billion$1.60 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHKMPFHikma Pharmaceuticals$0.963.46%N/AN/AN/AHTCMYHitachi Construction Machinery$1.232.07%N/A22.57%N/ALEGIFLEG ImmobilienN/AN/AN/AN/AN/AOUTKYOutokumpu Oyj$0.042.31%N/AN/A N/ALatest OUTKY, HTCMY, LEGIF, and HKMPF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/17/2025OUTKYOutokumpu Oyj$0.07104/7/20254/7/20254/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHKMPFHikma Pharmaceuticals0.461.660.98HTCMYHitachi Construction Machinery0.261.630.75LEGIFLEG ImmobilienN/AN/AN/AOUTKYOutokumpu Oyj0.071.540.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHKMPFHikma PharmaceuticalsN/AHTCMYHitachi Construction MachineryN/ALEGIFLEG ImmobilienN/AOUTKYOutokumpu OyjN/AInsider OwnershipCompanyInsider OwnershipHKMPFHikma PharmaceuticalsN/AHTCMYHitachi Construction MachineryN/ALEGIFLEG ImmobilienN/AOUTKYOutokumpu OyjN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHKMPFHikma Pharmaceuticals9,100221.89 millionN/ANot OptionableHTCMYHitachi Construction Machinery26,230106.35 millionN/ANot OptionableLEGIFLEG Immobilien2,00374.11 millionN/ANot OptionableOUTKYOutokumpu Oyj8,469913.74 millionN/ANot OptionableOUTKY, HTCMY, LEGIF, and HKMPF HeadlinesRecent News About These CompaniesOutokumpu Oyj (OUTKY) Q1 2025 Earnings Call Highlights: Strong Deliveries and Record Recycled ...May 9, 2025 | finance.yahoo.comQ1 2025 Outokumpu Oyj Earnings Call TranscriptMay 9, 2025 | gurufocus.comOutokumpu Oyj (OUTKY) Expected to Announce Earnings on TuesdayMay 1, 2025 | marketbeat.comOutokumpu Oyj (0FJ8) was downgraded to a Sell Rating at Morgan StanleyFebruary 27, 2025 | markets.businessinsider.comOutokumpu completes nuclear technology studyFebruary 19, 2025 | steeltimesint.comBarclays Sticks to Its Hold Rating for Outokumpu Oyj (0FJ8)February 19, 2025 | markets.businessinsider.comOutokumpu reins back US expansionFebruary 18, 2025 | recyclinginternational.comOutokumpu Oyj reports Q4 resultsFebruary 14, 2025 | seekingalpha.comOutokumpu Oyj (0FJ8) Receives a Hold from BarclaysFebruary 14, 2025 | markets.businessinsider.comMaterials Down After Outokumpu Warning -- Materials RoundupDecember 14, 2024 | marketwatch.comOutokumpu invests in biocarbon plantDecember 10, 2024 | steeltimesint.comOutokumpu warns of worsening steel markets after Q3 profit beatOctober 30, 2024 | msn.comKalmar electric forklift trucks to support Outokumpu’s emissions-reduction targets at Tornio steel plantSeptember 6, 2024 | msn.comOutokumpu Oyj (0FJ8.IL)August 24, 2024 | uk.finance.yahoo.comKepler Capital Remains a Sell on Outokumpu Oyj (0FJ8)August 10, 2024 | markets.businessinsider.comOutokumpu Oyj reports Q2 resultsAugust 10, 2024 | msn.comOutokumpu acknowledged for the second time as a Climate Leader in Europe by Financial TimesMay 16, 2024 | finance.yahoo.comOutokumpu acknowledged for the second time as a Climate Leader in Europe by Financial TimesMay 16, 2024 | prnewswire.comOutokumpu Oyj (OUT1V)March 6, 2024 | investing.comOutokumpu Oyj Class A OUT1VFebruary 25, 2024 | morningstar.comUPDATE 3-Finnish steelmaker Outokumpu sees European recovery continuingFebruary 9, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOUTKY, HTCMY, LEGIF, and HKMPF Company DescriptionsHikma Pharmaceuticals OTCMKTS:HKMPF$27.73 0.00 (0.00%) As of 05/27/2025Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.Hitachi Construction Machinery OTCMKTS:HTCMY$59.31 0.00 (0.00%) As of 05/27/2025Hitachi Construction Machinery Co., Ltd., together with its subsidiaries, manufactures and sells construction machineries worldwide. The company operates through two segments, Construction Machinery Business and Solution Business. It offers excavators and wheel loaders, hydraulic excavators, compaction equipment, and rigid dump trucks. The company also provides ICT construction solutions; ConSite that monitors machines' operational status and alarms by sending monthly operational reports, as well as notifies emergency alarms; Fleet management system, which offers real-time monitoring of dump truck for optimizing vehicle operations; and autonomous haulage system for autonomous operation of mining dump trucks. In addition, it provides parts and services; used equipment under the PREMIUM USED brand; machinery rental services under the PREMIUM RENTAL and REC brand names; and parts remanufacturing services. The company was incorporated in 1951 and is headquartered in Taito, Japan. Hitachi Construction Machinery Co., Ltd. is a subsidiary of Hitachi, Ltd.LEG Immobilien OTCMKTS:LEGIF$83.09 0.00 (0.00%) As of 05/27/2025LEG Immobilien SE, together with its subsidiaries, operates as an integrated property company in Germany. The company engages in the performance of services and management of equity investments; property management and location development; performance of services for third parties and housing industry services; and generation of electricity and heat activities. It also provides information technology (IT) services for third parties; and management services for third-party properties. The company's property portfolio consisted of residential units; commercial units; and garages and parking spaces in North Rhine-Westphalia. LEG Immobilien SE was founded in 1970 and is headquartered in Düsseldorf, Germany.Outokumpu Oyj OTCMKTS:OUTKY$1.73 0.00 (0.00%) As of 05/27/2025Outokumpu Oyj produces and sells various stainless steel products in Finland, other European countries, North America, the Asia-Pacific, and internationally. The company operates through three segments: Europe, Americas, and Ferrochrome. It offers cold rolled coils, strips, and sheets; hot rolled coils, strips, and plates; quarto plates; precision strips; and specialized components, such as welded stainless-steel I-beams, H-beams, hollow-section tubes, bent profiles, structural sections, hardened and customized press plates, suction roll shells, and blancs and disks. The company also provides stainless steel powder which includes Supra 316L, Dura 17-4PH, Ultra 904L, Therma 253MA, Dura 4116, and Ni-free austenitic stainless steel powder; and nickel-based alloys. Its products are used in various applications, including commercial kitchen, cooking, food industry, and home appliances; automotive and transportation; building and infrastructure; energy; marine; and heavy industries. The company was founded in 1910 and is headquartered in Helsinki, Finland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
